Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 862 for "ClinicalTrials.gov"
  1. ... syndrome VEXAS National Organization for Rare Disorders (NORD) ClinicalTrials.gov VEXAS SYNDROME; VEXAS PubMed Beck DB, Bodian DL, ...
  2. ... Stickler syndrome National Organization for Rare Disorders (NORD) ClinicalTrials.gov STICKLER SYNDROME, TYPE I; STL1 MARSHALL SYNDROME; MRSHS ...
  3. ... Essential hypertension National Organization for Rare Disorders (NORD) ClinicalTrials.gov HYPERTENSION, ESSENTIAL HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2 HYPERTENSION, ...
  4. ... deficiency syndrome National Organization for Rare Disorders (NORD) ClinicalTrials.gov HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS PubMed Camacho JA, ...
  5. ... pigmentosa syndrome National Organization for Rare Disorders (NORD) ClinicalTrials.gov NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA PubMed Chowers I, ...
  6. ... synthetase deficiency National Organization for Rare Disorders (NORD) ClinicalTrials.gov GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD GLUTATHIONE SYNTHETASE DEFICIENCY OF ...
  7. ... atrial fibrillation National Organization for Rare Disorders (NORD) ClinicalTrials.gov ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1 ATRIAL FIBRILLATION, FAMILIAL, ...
  8. ... type 3 National Organization for Rare Disorders (NORD) ClinicalTrials.gov SHORT QT SYNDROME 1; SQT1 SHORT QT SYNDROME ...
  9. ... Familial hypercholesterolemia National Organization for Rare Disorders (NORD) ClinicalTrials.gov HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1 HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FHCL2 ...
  10. ... type 2 National Organization for Rare Disorders (NORD) ClinicalTrials.gov HYPERPROLINEMIA, TYPE I; HYRPRO1 HYPERPROLINEMIA, TYPE II; HYRPRO2 ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next